Mild photothermal therapy for cancer cell modulation: A transformative approach to regulate cancer cell phenotype and enhance therapeutic outcomes

Jinyuan Liu; Steve Smith; Congzhou Wang

doi:10.1016/j.jpha.2025.101185

Volume 14 Issue 12

Dec. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2024 > 14(12): 101185

Jinyuan Liu, Steve Smith, Congzhou Wang. Mild photothermal therapy for cancer cell modulation: A transformative approach to regulate cancer cell phenotype and enhance therapeutic outcomes[J]. Journal of Pharmaceutical Analysis, 2024, 14(12): 101185. doi: 10.1016/j.jpha.2025.101185

Citation:

Jinyuan Liu, Steve Smith, Congzhou Wang. Mild photothermal therapy for cancer cell modulation: A transformative approach to regulate cancer cell phenotype and enhance therapeutic outcomes[J]. Journal of Pharmaceutical Analysis, 2024, 14(12): 101185. doi: 10.1016/j.jpha.2025.101185

Citation:

Jinyuan Liu, Steve Smith, Congzhou Wang. Mild photothermal therapy for cancer cell modulation: A transformative approach to regulate cancer cell phenotype and enhance therapeutic outcomes[J]. Journal of Pharmaceutical Analysis, 2024, 14(12): 101185. doi: 10.1016/j.jpha.2025.101185

PDF( 962 KB)

Mild photothermal therapy for cancer cell modulation: A transformative approach to regulate cancer cell phenotype and enhance therapeutic outcomes

doi: 10.1016/j.jpha.2025.101185

1. Nanoscience and Biomedical Engineering, South Dakota School of Mines and Technology, Rapid City, SD, 57701, USA;
2. State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China;
3. Nanoscience and Biomedical Engineering, South Dakota School of Mines and Technology, Rapid City, SD, 57701, USA

Funds:

The authors thank the support from the National Science Foundation CAREER Award, USA (Grant No.: 2143972), and the National Institutes of Health through the Award, USA (Grant No.: R15CA274349).

Available Online: Feb. 10, 2025
Publish Date: Jan. 28, 2025

Abstract

FullText(HTML)

References(5)

References

[1]	J. Yang, P. Antin, G. Berx, et al., Guidelines and definitions for research on epithelial-mesenchymal transition, Nat. Rev. Mol. Cell Biol. 21 (2020) 341-352.
[2]	X. Deng, Z. Shao, Y. Zhao, Solutions to the drawbacks of photothermal and photodynamic cancer therapy, Adv. Sci. 8 (2021), 2002504.
[3]	J. Liu, S. Smith, C. Wang, Photothermal attenuation of cancer cell stemness, chemoresistance, and migration using CD44-targeted MoS₂ nanosheets, Nano Lett. 23 (2023) 1989-1999.
[4]	J. Liu, S. Smith, C. Wang, Reversing the epithelial-mesenchymal transition in metastatic cancer cells using CD146-targeted black phosphorus nanosheets and a mild photothermal treatment, ACS Nano 16 (2022) 3208-3220.
[5]	J. Liu, L. Kang, S. Smith, et al., Transmembrane MUC18 targeted polydopamine nanoparticles and a mild photothermal effect synergistically disrupt actin cytoskeleton and migration of cancer cells, Nano Lett. 21 (2021) 9609-9618.